DRTS Alpha Tau Medical: Enterprise Value-to-Revenue Multiple

Alpha Tau Medical (DRTS) - corporate logo

Alpha Tau Medical Ltd. (DRTS) is integrating ESG principles into the development of alpha-therapy systems by controlling isotope disposal. The historical EV/Sales trend illustrates the business valuation dynamics, where the 0.00 mark reflects the current state. However, narrow specialization and technology implementation challenges create risks for profitability. The Israeli developer is currently focusing on the organic growth of laboratories in the US, conducting global trials independently.

DRTS: Alpha Tau Medical Ltd. EV/Sales Multiple 11/23/2025 - 11/20/2026

DRTS (Alpha Tau): analytical breakdowns and indicator data

- current price and projected stock value:
- company stock capitalization data:
Initial company analysis:DRTS, Alpha Tau Medical Ltd.
Core merchandise of Alpha Tau Medical Ltd

Alpha Tau Medical Ltd. (DRTS) is integrating bioethics principles and ESG standards into the production of alpha-therapy systems. The EV/Revenue multiple assesses the business value inclusive of net debt, eliminating the impact of the financing structure. This indicator measures the market value of one dollar of sales, reflecting investor expectations regarding growth rates. This chart reveals an overvaluation of assets amid technological breakthroughs. A decline in this metric signals that the company is undervalued relative to its operational efficiency.